Medicare Enrolled

Dr. Brijeshwar Maini, M.D.

Cardiovascular Disease · West Palm Beach, FL
Speaking/Promotional
1411 N FLAGLER DR STE 8000, West Palm Beach, FL 33401
5614070611
In practice since 2005 (20 years)
NPI: 1215938063 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Maini from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maini? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Maini

Dr. Brijeshwar Maini is a cardiovascular disease in West Palm Beach, FL, with 20 years in practice.

Between the years covered by Open Payments, Dr. Maini received a total of $133,423 from 28 pharmaceutical and/or device companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Maini is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice$ $133,423 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$133,423
Total received (2018-2024)
Avg $19,060/year across 7 years
Top 4% in FL for cardiovascular disease
28
Companies
470
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$71,028 (53.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$35,609 (26.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,787 (20.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$239
2023
$273
2022
$30,537
2021
$15,673
2020
$26,600
2019
$27,650
2018
$32,451

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$45,754
Boston Scientific Corporation
$30,619
Philips Electronics North America Corporation
$27,011
Medtronic Vascular, Inc.
$11,290
Edwards Lifesciences Corporation
$8,995
Siemens Medical Solutions USA, Inc.
$6,619
BOSTON SCIENTIFIC CORPORATION
$602
ATRICURE, INC.
$601
Shockwave Medical, Inc
$352
Medtronic, Inc.
$276
Janssen Pharmaceuticals, Inc
$157
LivaNova USA, Inc.
$156
BIOTRONIK INC.
$127
CARDIVA MEDICAL, INC.
$107
Regeneron Healthcare Solutions, Inc.
$106
Amgen Inc.
$93
Biosense Webster, Inc.
$76
Bard Peripheral Vascular, Inc.
$70
AstraZeneca Pharmaceuticals LP
$65
JenaValve Technology, Inc.
$60
ABIOMED
$58
Cardinal Health 200, LLC
$50
AngioDynamics, Inc.
$41
CORDIS US CORP.
$37
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Cardiovascular Systems Inc.
$30
ACIST MEDICAL SYSTEMS, INC.
$21
Chiesi USA, Inc.
$20
Top 3 companies account for 77.5% of total payments
Associated products mentioned in payments ›
(6342) Intrasight Integrated · (9520) IGT Devices Und · (9520) IGT Devices Undivided · (9547) IGT Systems Und · AMPLATZER · AMPLATZER Occluders · ATRICURE ATRICLIP LAA EXCLUSION · Advisa · Aortic Tissue Valve - Perceval · Artis Q · Artis pheno · Asahi Fielder coronary guide wire · BRILINTA · Bioprosthetic Mitral Valve · COREVALVE EVOLUT R · CRM-Research only · CVI CONSUMABLES · CardioMEMS HF System · Cardiovascular-Research only · Carto 3 · CentriMag · CoreValve Evolut · Coronary Orbital Atherectomy System · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · GENERAL STRUCTURAL HEART · GENERAL THERAPIES · GENERAL VASCULAR ACCESS · GENERAL - STRUCTURAL HEART · GENERAL - THERAPIES · GENERAL STENTS · GENERAL STRUCTURAL HEART · GENERAL VASCULAR ACCESS · General - Structural Heart · General - Vascular Access · Impella · JARDIANCE · JenaValve Pericardial TAVR System · KENGREAL · M2000 RealTime System · M2000 system · MICRA · MITRACLIP · Mini Trek catheters · Mitra Clip system · MitraClip System · Mosaic · MynxGrip Vascular Closure Device · NA · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · RADIAL 360 · RAIN SHEATH · RESOLUTE ONYX · Repatha · SAPIEN 3 Ultra RESILIA · SC2000 · SYNERGY ABLATION SYSTEM · THERAPIES · TMVR · TRUE · Tendyne Mitral Valve System · Tricuspid Valve Repair System · Trifecta GT Tissue Heart Valve · VALIANT CAPTIVIA · Vascular Closure Device · Vascular Lithotripsy · WATCHMAN · WATCHMAN Access System · Watchman · XARELTO · Xience Alpine cornary stent system · Xience cornary stent systems
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (53%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for cardiovascular disease in FL.

Looking for a cardiovascular disease in West Palm Beach?
Compare cardiovascular diseases in the West Palm Beach area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
132
Per 100K population
8.8
County median income
$81,115
Nearest hospital
GOOD SAMARITAN MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Maini is a cardiovascular disease, and high industry engagement (speaking/promotional, top 4%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Maini receive payments from pharmaceutical companies?
Yes. Dr. Maini received a total of $133,423 from 28 companies across 470 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Maini) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Cardiovascular Diseases in West Palm Beach
Browse cardiovascular diseases in West Palm Beach ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Philips Electronics North America Corporation Payments to Doctors
See all physicians who received payments from Philips Electronics North America Corporation.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →